ETON Eton Pharmaceuticals, Inc.

BEARISH Impact: 5/10 144
Horizon days Filed May 28, 2026 Processed 15d 18h ago SEC 0001949846-26-000326
Form 144 — notice of proposed sale of securities
Latest settled — T+5d
ETON ▼ -13.34% at T+5d
SHORT call ✓ call won +13.34% · α vs SPY +13.29% · entry $31.86 → $27.61
Next anchor: T+20d in 13d
Currently $31.59 · +0.85% from $31.86 entry (call sign-flipped)
Entry anchored
May 28, 03:10 PM ET
via Databento tick
T+1d
-4.43%
call +4.43% · α +4.67%
$30.45
settled 15d ago
T+5d
-13.34%
call +13.34% · α +13.29%
$27.61
settled 9d ago
T+20d
call — · α —
in 13d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Sean Brynjelsen filed a Form 144 indicating intent to sell 120,000 common shares valued at approximately $3.89 million, representing about 0.44% of the company's $888M market cap. The shares were acquired as founder shares and open-market purchases, and the sale is planned through a broker at current market prices.

Actionable Insight

CEO's intent to sell a meaningful stake ahead of any upcoming catalysts warrants monitoring. While the sale is not yet executed, the filing signals insider desire to monetize. Watch for actual Form 4 filings and any upcoming earnings or pipeline updates that could explain the timing.

Key Facts

  • CEO Sean Brynjelsen filed Form 144 to sell 120,000 shares
  • Estimated proceeds: ~$3.89 million at $32.40/share
  • Shares acquired as founder shares and open-market purchases dating back to 2017
  • Sale represents ~0.44% of $888M market cap
  • Recent insider activity: 3 sells totaling $2.9M in past 30 days

Financial Impact

CEO plans to sell ~$3.89M in stock, a notable insider sale relative to recent insider activity of $2.9M in prior 30 days

insider sellingdilution

Risk Factors

  • CEO selling may signal lack of confidence in near-term prospects
  • Potential overhang if sale is executed over time
  • Recent insider selling cluster (3 sells, $2.9M in 30 days) amplifies concern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001949846-26-000326
Document: 0001949846-26-000326-index.html0001949846-26-000326
Document: 0001949846-26-000326.txt0001949846-26-000326
11 reports for ETON
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+60▲ +95.18%Feb 25, 2026
Filters
Rows
Reports for ETON — sortable, filterable
Type Now
May 29, 2026
14d ago
Insider Cluster
BEARISH ★ 5/10
$28.68 $29.13▼ −1.57%▼ −4.32%$31.59 (−10.15%)
May 28, 2026
15d ago
144
BEARISH ★ 5/10
$31.86 $27.61▲ +13.34%▲ +13.29%$31.59 (+0.85%)
May 19, 2026
24d ago
8-K
BULLISH ★ 6/10
$34.45 $32.40▼ −5.95%▼ −7.19%$31.59 (−8.30%)
Apr 27, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$23.45 $30.16▲ +28.61%▲ +28.21%$31.59 (+34.71%)
Apr 27, 2026
6w ago
Press Release
MIXED ★ 5/10
$23.45 $30.16▲ +28.61%▲ +28.21%$31.59 (+34.71%)
Apr 16, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$24.43 $22.97▼ −5.98%▼ −6.96%$31.59 (+29.31%)
Apr 15, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$24.43 $22.97▼ −5.98%▼ −6.96%$31.59 (+29.31%)
Mar 3, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$17.53 $18.09▲ +3.19%▲ +4.53%$31.59 (+80.21%)
Mar 2, 2026
14w ago
Press Release
BULLISH ★ 7/10
$18.15 $16.70▼ −7.99%▼ −6.78%$31.59 (+74.05%)
Feb 28, 2026
15w ago
Institutional Cluster
BULLISH ★ 6/10
$18.15 $16.70▼ −7.99%▼ −6.78%$31.59 (+74.05%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (47h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access